Hongcan Shi
About
In The Last Decade
Hongcan Shi
67 papers receiving 990 citations
Peers
Comparison fields: 5 of 105
- Biomaterials 348
- Surgery 318
- Biomedical Engineering 263
- Pulmonary and Respiratory Medicine 251
- Molecular Biology 232
Countries citing papers authored by Hongcan Shi
This map shows the geographic impact of Hongcan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongcan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongcan Shi more than expected).
Fields of papers citing papers by Hongcan Shi
This network shows the impact of papers produced by Hongcan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongcan Shi. The network helps show where Hongcan Shi may publish in the future.
Co-authorship network of co-authors of Hongcan Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Hongcan Shi. A scholar is included among the top collaborators of Hongcan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongcan Shi. Hongcan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | 1 | |
| 9 | 8 | |
| 10 | 1 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 57 | |
| 14 | 25 | |
| 15 | 4 | |
| 16 | Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. | 12 |
| 17 | 15 | |
| 18 | 8 | |
| 19 | 10 | |
| 20 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.